Phase 1 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 70 years old (inclusive)
- You weigh between 50 and 100 kg, and your body mass index (BMI) is between 18 and 32 (a measure of weight relative to height — confirm with trial site if unsure)
- You have been officially diagnosed with Rheumatoid Arthritis (RA) based on recognised medical guidelines
- You are willing and able to stay at the trial site when required, attend scheduled visits, and follow the study plan including any tests
- You are willing and able to follow the birth control and lifestyle rules set out by the study
Who may not be able to join:
- You have a known history of any other significant medical condition besides RA
- You have been diagnosed with, or have symptoms of, any other condition where the immune system attacks the body (other than RA)
- You have tested positive for Hepatitis A, Hepatitis B, or Hepatitis C
- You have tested positive, unclear, or had an invalid test result for tuberculosis (TB)
- You currently smoke more than 5 cigarettes per day, or the equivalent amount of tobacco
- You are currently pregnant, breastfeeding, or plan to become pregnant during the study
- You have taken part in another clinical trial or received an experimental drug within the last 30 days, or within a certain timeframe based on how long the previous drug stays in your body (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 781-201-4781
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety and Tolerability of Single Ascending Doses of JADE201 in participants with Rheumatoid Arthritis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.